MS Center of Excellence
Welcome to the Multiple Sclerosis Center of Excellence located in Foothills Neurology, Phoenix AZ. Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body.
- MS Clinical Trials in Arizona
- What is MS? Brochure
- MS Research Update Published in February 2014, this update is a comprehensive overview of research findings on the FDA-approved disease-modifying therapies, as well as many experimental treatments
Written by Stephen Krieger, MD with Diana Schneider, PhD
Multiple Sclerosis Facts
External Sources and Resources
Many effective medications are available for the treatment of multiple sclerosis (MS). These types of drugs may be prescribed for three different categories of MS treatment. The first area of treatment is to slow MS activity and progression; the second area is to reduce the severity and duration of a relapse; and the third area is to treat the symptoms of MS individually. All of these medications are prescribed by a physician – usually a neurologist who specializes in MS. Individuals considering a change to their present treatment regimen should always consult their physician.
Multiple sclerosis (MS) was first described by French neurologist Jean-Martin Charcot in 1868. Yet, after more than 140 years of research into the disease, much remains a mystery. There is no known cause, and as yet, no cure. However, there are treatments that can slow the progress of the disease and manage the symptoms, and new research is expanding our understanding of this unpredictable illness.
In addition, not all people experience the same pattern of MS progression. There are four categories that describe the typical ways in which MS evolves over time.
Relapsing-remitting MS (RRMS)
This is the most common form of MS (85% of all cases) and is characterized by times of active inflammation—often called flare ups, exacerbations, or relapses—followed by periods where you may experience little or no discomfort.
Secondary-progressive MS (SPMS)
SPMS describes a case of progressive MS that develops after (or secondary to) a primary relapsing-remitting course. Most cases of RRMS will eventually evolve into SPMS.
Primary-progressive MS (PPMS)
About 10% of people with MS are diagnosed with PPMS. PPMS is characterized by symptoms that worsen slowly and gradually. There may be brief periods of improvement, but the general course of the disease is defined by decreasing functionality.
Progressive-relapsing MS (PRMS)
This is the least common of the four subtypes of MS. PRMS combines the progressive features of PPMS with occasional relapses over time. Recovery after an attack is sometimes, but not always noted.
The National MS Society is working toward a world free of MS. We mobilize people and resources to drive research for a cure and to address the challenges of everyone affected by MS.
At MultipleSclerosis.net we empower patients and caregivers to take control of MS by providing a platform to learn, educate, and connect with peers and healthcare professionals.